- 24/7 Wall St.•2 days ago
24/7 Wall St. has picked out some of the major companies in the health care sector that are moving ahead of the first presidential debate and added in some color for each.
- GlobeNewswire•2 days agoFate Therapeutics Receives FDA Orphan Drug Designation for ProTmune™ in Allogeneic Hematopoietic Cell Transplantation
SAN DIEGO, Sept. 26, 2016-- Fate Therapeutics, Inc., a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced today that ...
Fate Therapeutics, Inc. (FATE)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Ask||8.55 x 5000|
|Day's Range||3.05 - 3.46|
|52wk Range||1.46 - 6.71|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-3.02|
|Avg Vol (3m)||288,640|
|Dividend & Yield||N/A (N/A)|